See also this year's filing and all EDGAR filings for this company.
PDF Report 0001442836_2023_Mersana_Therapeutics_Inc.pdf
Logs
| error | IME and Company effects mismatched for Assets, Current. IME Effects: 29.0, Company Effect: 28.9 | subcommand.report | {} |
| info | original effects; company_effects: 28.95, ime_effects: 29.0 | subcommand.report | {} |
Graph
Absolute values for 0001442836, Mersana Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 319,219,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,985,000 |
| 3 | remainder_Assets | 11,136,000 |
| 4 | LiabilitiesCurrent | 91,533,000 |
| 5 | LiabilitiesNoncurrent | 150,750,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 56,963,000 |
| 9 | ResearchAndDevelopmentExpense | 173,385,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 26,581,000 |
| 12 | remainder_NetIncome | -445,000 |
| 13 | remainder_ComprehensiveNetIncome | -152,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 334,340,000 |
| 1 | Liabilities | 242,283,000 |
| 2 | Expenses | 230,348,000 |
| 3 | Revenues | 26,581,000 |
| 4 | StockholdersEquity | 92,057,000 |
| 5 | NetIncome | -204,212,000 |
| 6 | ComprehensiveNetIncome | -204,288,000 |
| 7 | BaseVar | 417,074,500 |
| 8 | EconomicCapitalRatio | -0.159 |
Edgar->Model Mapping
Feature Distribution
Change over Time
